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WELCOME TO THE CONFERENCE 
 
We take great pleasure in setting aside our regular lab work and welcoming you all to 
the International Conference on Cyclophilins and other Foldases - Cell Signaling 
Catalysts and Drug Targets, which will be held at the Martin-Luther-University Halle-
Wittenberg, Germany from September 19th to 22th, 2013.  
In the last few years, the scientific and biotechnological communities have become 
increasingly interested in the challenges involved in conformational regulation of 
bioactivities by endogenous factors such as foldases. This is reflected in the number 
of over 600 papers published during 2012 about the enzymes addressed in this 
conference. We are just beginning to understand how catalyzed conformational 
interconversions of peptide bonds may affect protein functioning under physiological 
and pathophysiological conditions. This conference is thought to provide an unique 
forum for researchers to present and exchange new data and to call attention on all 
aspects of foldase enzymes and their inhibitors. We are pleased to see many 
prominent scientists come lecturing here in their special fields extending the 
biochemical studies to biomedicine and potential clinical applications.  
Halle, with its 230.000 inhabitants, is situated along the river Saale. Our conference 
venue belongs to the Martin-Luther University Halle-Wittenberg, which is one the 
oldest universities in Germany. You will find Germany´s National Academy of 
Sciences, Leopoldina just a few steps from the conference venue indicating that 
Halle (Saale) is a good place to discuss and to plan scientific activities. 
Also important, along the streets and lanes of the city you will find many coffee shops 
and restaurants where you can sit and listen to the city's buzz. 
We truly hope you will enjoy the conference and your days in Halle (Saale). 
   






The symposium will be held in the Auditorium Maximum (Audimax) at the Martin-
Luther-University Halle-Wittenberg, Lecture hall XXII, Universitätsplatz 1, 06108 
Halle (Saale), Germany. 
 
Conference Office 
The conference office is located in the foyer of the Audimax and will be open from 11 
am on September 19, 2013 and on the following days of the symposium from 7:30 
a.m. till the end of the sessions. 
Wireless LAN access is available at the conference office. 
 
Registration 
All participants are kindly requested to visit the conference office after arrival. All 
necessary conference materials will be distributed together with the conference bag. 
 
Badges 
All participants are kindly requested to wear their badges throughout the conference 
for identification and admittance to the sessions and social events. Members of the 
organization staff will wear yellow badges. 
 
Lunches 
All participants are kindly requested to arrange for their own lunch. Lunch is available 
from several different local restaurants and coffee shops within walking distance. At 
the marketplace and in Große Ullrichstraße, there are also several take-aways. 
Several lunch opportunities are marked on the map (page 3). 
 
Transportation 
Halle has a public transportation system operating a tram and bus network. Please 
be sure to validate your ticket in the tram. 
 
Money Exchange 
All banks offer money exchange according to the official current exchange rates. 
Common credit cards are accepted in most shops and restaurants. 
 
  




In case of late arrival please contact the hotels. 
 
Conference hotels are: 
Dorint Charlottenhof Halle 
Dorotheenstraße 12 
06108 Halle  
0345 / 29230 





0345 / 2323200 
The conference venue can be easily reached from the hotel by foot (20 min walk). 
 
Maritim Hotel Halle  
Riebeckplatz 4 
06110 Halle 
0345 / 51010 
The conference venue can be reached from the hotel by foot (20 min walk) or by 
tram (line 2, 4, 5, 7, 9 and 12). 
 
Best Western Grand City Hotel Halle 
Neustädter Passage 5 
06122 Halle (Halle-Neustadt) 
0345 / 69310 
 
Guests of this hotel travel free-of-charge on public transport in Halle. To the 
conference venue it is recommended to go by tram to the market place (line 2 or 10, 
11 min). From the market place back to the hotel please use line 2 (direction Soltauer 
Straße) or line 10 (direction Göttinger Bogen) each departing every 15 min. The tram 
stop is right in front of the hotel (Zentrum Neustadt). 
  





All participants are kindly invited to the following social events: 
 
On Thursday, 19 September 2013, at 8:00 p.m. there will be a 
       Welcome Reception at the Stadthaus Halle.  
The Stadthaus is the neo-gothic building located at the south side of the 
market place (Markt 2). 
 
On Saturday, 21 September 2013, at 8:00 p.m. there will be the 
        Conference Dinner at the Maritim Hotel Halle.  
The Maritim Hotel Halle can be found within walking distance of the 




On Friday, 20 September 2013, at 8:00 p.m. there will be  
        a Guided Evening Tour in the State Museum of Prehistory. 
The museum is located at Richard-Wagner-Str. 9. It can be reached most 
easily by taking tram 7. The tram station directly located in front of the 
museum is called “Landesmuseum für Vorgeschichte”. 
or alternatively, 
a Guided Evening Tour in the Museum Händel-Haus, the birthplace of 
George Frideric Handel. The museum is located at Große Nikolaistraße 5 
and can be found within walking distance of the conference venue. 
Please sign up for the event of your choice at the conference office. 
 
 
On Friday, 20 September 2013, at 7:30 p.m. there will be a  
        Sponsor’s Dinner at the Moritzburg Castle Halle. 
Separate invitations for this event will be presented  




For accompanying guests: 
For accompanying guests we offer ad hoc arrangements of excursions, guided city 
tours or museum visits. 
Please contact the conference office for organization and support. 
  






There will be plenary lectures (45 min), keynote topics (30 min) and oral 
communications (30 or 20 min). All times include discussion. 
The program will also include posters. In microsymposia, there will be selected oral 
presentations in the lecture hall based on posters displayed in the poster area. 
 
Conference Language 
English is the official language of the symposium. 
 
 
Lectures and Oral Presentations 
All lectures will be held at the Auditorium Maximum, Lecture hall XXII, 
Universitätsplatz 1, Halle. Authors are kindly requested to load and to check their 




Poster sessions will be held in the foyer area of the Auditorium Maximum, 
Universitätsplatz 1, Halle. Poster authors are recommended to hang all posters on 
September, 19. 
 
Two poster sessions with discussion at the stands are scheduled for September 20 
(posters with odd numbers) and September 21 (posters with even numbers). Each 
poster will be allotted a panel of size: 90 cm in width and 120 cm in high.  
 
Microsymposia 
In microsymposia, there will be selected oral presentations in the lecture hall based 
on posters displayed in the poster area. Oral presentation must be no longer than 8 
min. No more than 5 slides are permitted. There will be no time for discussion in the 













 September 21 
 Registration open from 7:30 a.m. Registration open from 7:30 a.m. 
 Session 2 Session 4 
 8:30 – 8:50 
Chad Dickey (L-11) 
8:30 – 9:15 Plenary 
Kun Ping Lu (L-27) 
 8:50 – 9:10 
Felix Hausch (L-12) 
9:15 – 9:45 
Steven Hanes (L-28) 
 9:10 - 9:30 
Tracy Robson (L-13) 
9:45 - 10:05 
Len Kritharides (L-29) 
 9:30 - 9:50 




open from 11 a.m. 
9:50 - 10:20 
Coffee break 
10:05 - 10:35 
Coffee break 
 10:20 - 10:40 
Michael Steinert (L-15) 
10:35 - 11:05 
Donald Hamelberg (L-30) 
 10:40 - 11:00 
Holger Barth (L-16) 
11:05 - 11:35 
Dorothee Kern (L-31) 
Conference posters will be on 
display for the duration of the 
conference 
11:00 - 11:20 
Patrizia Nigro (L-17) 
11:35 - 11:55 
Xavier Hanoulle (L-32) 
 11:20 - 11:40 
Joan C. Marini (L-18) 
11:55 - 12:15 
Valentina Bonetto (L-33) 
 11:40 - 12:00 
Hans Peter Bächinger (L-19) 
12:15 - 12:35 
Paulo A. Ferreira (L-34) 
 12:00 - 12:20 






Session 1 Session 3 Session 5 
14:00-14:20  
Opening remarks and history 
Gunter Fischer (L-01) 
14:00 – 14:45 Plenary 
Bradford C. Berk (L-21) 
14:00 – 14:30 
Jun O. Liu (L-35) 
14:20 – 15:05 Plenary 
Philippe Gallay (L-02) 
14:45 – 15:15 
Andreas E. May (L-22) 
14:30 – 15:00 
Michael Bukrinsky (L-36) 
15:05 – 15:35 
Jeremy Luban (L-03) 
15:15 – 17:15 
Microsymposium I 
and coffee break 
15:00-16:50 
Microsymposium II 
and coffee break 
15:35 – 15:55 
Peter Probst (L-04) 
17:15 – 17:45 
James S. Malter (L-23) 
16:50 – 17:20 
Charles Clevenger (L-37) 
15:55 – 16:25 
Coffee break 
17:45 – 18:05 
Takafumi Uchida (L-24) 
17:20 – 17:40 
Thomas Ratajczak (L-38) 
16:25 – 16:45 
Angus Bell (L-05) 
18:05 – 18:25 
Felicia A. Etzkorn (L-25) 
17:40 – 18:00 
Eva Obermayr (L-39) 
16:45 – 17:15 
Etienne E. Baulieu (L-06) 
18:25 – 18:45 
Guy Lippens (L-26) 
18:00 – 18:20 
Kimio Satoh (L-40) 
17:15 – 17:35 
Veerle Baekelandt (L-07) 
 18:20 – 18:40 
Franz X. Schmid (L-41) 
17:35 – 17:55 
Mario Galigniana (L-08) 
 18:40 – 19:00 
Jochen Balbach (L-42) 
17:55 – 18:25 
Maria Fiammetta Romano  
(L-09) 
  
18:25 – 18:45 
Hans Fliri (L-10) 
  
   
18:45 End of the session 18:45 End of the session 19:00 End of the session 
20:00 Welcome Reception Special events 20:00 Conference Dinner 
   




Thursday, September 19                                                  
Session 1 




MPI BPC Göttingen, BO Halle, Germany 
 OPENING REMARKS AND HISTORY 
14:20 L-02 
Philippe Gallay 
 Department of Immunology & Microbial Science, La Jolla, CA, USA 
CYCLOPHILINS, CYCLOPHILIN INHIBITORS AND HEPATITIS C VIRUS 
15:05 L-03 
Jeremy Luban 
 University of Massachusetts Medical School, Worcester, MA, USA 
THE HIV-1 CAPSID AND CONSERVATION OF AN ANCIENT 
CYCLOPHILIN A BINDING LOOP 
15:35 L-04 
Peter Probst1, Sarah Mosier1, Bernard Scorneaux1, Ann Sluder1, Koichi 
Watashi2, Katyna Borroto-Esoda1  
  1Scynexis Inc., Durham, NC, USA, 2National Institute of Infectious Diseases, Tokyo, Japan 
THE IMMUNOMODULATORY ROLE OF THE NON-
IMMUNOSUPPRESSIVE CYCLOPHILIN INHIBITOR SCY-635 IN THE 
TREATMENT OF HEPATITIS C 
 
15:55 Coffee break 
Session 1 continued 
Chair: Philippe Gallay 
 
16:25 L-05 
Angus Bell, Paul Monaghan, Wesley Shaw 
 Trinity College Dublin, Dublin, Ireland 
ON THE MECHANISMS OF ANTIMALARIAL ACTION OF FK506, 
RAPAMYCIN AND NON-IMMUNOSUPPRESSIVE CONGENERS 
16:45 L-06 
Etienne Emile Baulieu1, Béatrice Chambraud1, Marcel Tawk1, Julien 
Giustiniani1, Geri Meduri1, Guy Lippens2 
Institut National de la Santé et de la Recherche Médicale, Le Kremlin-Bicêtre Cedex, France, 
2Université de Lille, Villeneuve d'Ascq, France 
INTERACTION OF FKBP52 WITH TAU: PATHOPHYSIOLOGICAL 
ASPECTS 
  




Angelique Deleersnijder, Melanie Gerard, Francesca Macchi, Anke Van 
der Perren, Chris Van den Haute, Veerle Baekelandt  
  Laboratory for Neurobiology and Gene Therapy, KU Leuven, Belgium 
UNRAVELING THE ROLE OF FK506 BINDING PROTEINS IN THE 
AGGREGATION AND NEUROTOXICITY OF α−SYNUCLEIN, A KEY 
PLAYER IN PARKINSON’S DISEASE 
17:35 L-08 
Mariana Lagadari1, Cristina Daneri1, Luciana Gallo1, Graciela Piwien-
Pilipuk1, Mario Galigniana1,2 
1Instituto de Biología y Medicina Experimental (IBYME) Buenos Aires, Argentina, 2University of 
Buenos Aires, Buenos Aires, Argentina 
MITOCHONDRIAL LOCALIZATION AND ANTIAPOPTOTIC PROPERTIES 
OF FKBP51 AND CYCLOPHILIN A 
17:55 L-09 
Simona Romano, Giovanna Nappo, Maria Fiammetta Romano 
 University Federico II, Naples, Italy 
FK506 BINDING PROTEIN 51 (FKBP51) PLAYS A ROLE AS 
TRANSCRIPTIONAL CO-REGULATOR OF MELANOMA STEMNESS 
18:25 L-10  
Hans Fliri 
Selcia Ltd., Fyfield Business & Research Park, Ongar, Essex, United Kingdom 
 PROLYL ISOMERASES: INDUSTRY’S NEGLECTED CHILD 
 
Friday, September 20 
Session 2 
Chair: Jochen Balbach 
 
8:30 L-11 
Laura Blair1, Shannon Hill2, Matt Scaglione3, Carl Cotman4, Henry 
Paulson3, Martin Muschol2, Vladimir Uversky2, 6, Torsten Klengel7, 
Elisabeth Binder7, Rakez Kayed8, Todd Golde5, Nicole Berchtold4, Chad 
Dickey1  
1,2University of South Florida, Department of Molecular Medicine, Tampa, FL, USA, 3University 
of Michigan, Ann Arbor, MI, USA, 4Univeristy of California, Irvine, CA, USA, 5University of 
Florida, Gainesville, FL, USA, 6Russian Academy of Sciences,Pushchino, Moscow Region, 
Russia, 7Max Planck Institute of Psychiatry, Munich, Germany, 8The University of Texas Medical 
Branch, Galveston, TX, USA 
FKBP51 COORDINATES WITH HSP90 TO FACILITATE NEURO-




 Max Planck Institute of Psychiatry, Munich, Germany 
 THE PROSPECT OF FKBP51 AS A DRUG TARGET 





Lana McClements1, Anita Yakkundi1, Angelos Papaspyropoulos4, 
Hannah Harrison3, Matthew P. Ablett3, Puthen V. Jithesh5, Hayley D. 
McKeen1, Rachel Bennett1, Christopher Donley1, Adrien Kissenpfennig2, 
Helen O. McCarthy1, Eric O’Neill4, Robert B. Clarke3, Tracy Robson1 
1,2 Queen’s University Belfast, Belfast, United Kingdom, 3University of Manchester, Manchester, 
United Kingdom, 4University of Oxford, Oxford, United Kingdom, 5University of Liverpool, United 
Kingdom 
TARGETING TREATMENT RESISTANT BREAST CANCER STEM CELLS 
WITH FKBPL AND ITS PEPTIDE DERIVATIVE, AD-01 
9:30 L-14 
Adina Breiman, David Meiri, Shikma Nachmani, Anat Milgrom 
Department of Molecular Biology and Ecology of Plants, Tel Aviv University, Tel Aviv, Israel 
THE PLANT LARGE FKBPs INTERACT WITH Hsp90 AND ARE 
INVOLVED IN DEVELOPMENT AND THERMOTOLERANCE 
 
9:50 Coffee break 
Session 2 continued 
Chair: Jeremy Luban 
10:20 L-15 
Michael Steinert1, Can Ünal1, Janine Rasch1, Kai Schwedhelm2, 
Alexandra Thiele3, Matthias Weiwad3, Kristian Schweimer4, Gunter 
Fischer6, Cornelius Faber5 
1Technische Universität Braunschweig, Braunschweig, Germany, 2University of Würzburg, 
Würzburg, Germany, 3Martin Luther University Halle-Wittenberg, Halle (Saale), Germany, 
4Universität Bayreuth, Bayreuth, Germany,5 Universitätsklinikum Münster, Münster, Germany, 
6MPI BPC Göttingen, BO Halle, Germany 
FUNCTION OF LEGIONELLA PNEUMOPHILA MIP DURING HUMAN 
INFECTION  
10:40 L-16 
Katharina Ernst1, Eva Kaiser1, Cordelia Schiene-Fischer2, Holger Barth1 
1University of Ulm Medical Center, Ulm, Germany, 2Martin-Luther-University Halle-Wittenberg, 
Halle (Saale), Germany 
CYCLOPHILINS AND FK506 BINDING PROTEINS BIND TO AND 
MEDIATE MEMBRANE TRANSPORT OF BACTERIAL ADP-
RIBOSYLATING TOXINS 
11:00 L-17 
Patrizia Nigro1, Stefania Straino2, Giulio Pompilio1, Bradford C. Berk3, 
Maurizio C. Capogrossi2  
1Centro Cardiologico Monzino-IRCCS, Milan, Italy, 2Laboratorio di Patologia Vascolare -IRCCS, 
Rome, Italy, 3University of Rochester School of Medicine and Dentistry, Rochester, NY, USA 
ROLE OF CYCLOPHILIN A IN ISCHEMIA AND REGENERATION 
  





Wayne A. Cabral1, Irina Perdivara2, MaryAnn Weis3, Masahiko Terajima4, 
Angela R. Blissett1, Weizhong Chang1, Elena Makareeva5, Sergey 
Leikin5, David Eyre3, Mitsuo Yamauchi4, Joan C. Marini1 
1NICHD, NIH, USA, 2NIEHS, NIH, USA, 3University of Washington, Seattle, WA, USA  
4University of North Carolina, Chapel Hill, NC, USA, 5Physical Biochemistry, NICHD, NIH, USA 
PPIB KO MOUSE: DIRECT EFFECTS ON COLLAGEN FOLDING AND 
GLYCOSYLATION, AND INDIRECT EFFECT ON LH1, ALTERING BONE 
CROSSLINK PATTERNS 
11:40 L-19 
Hans Peter Bächinger, Yoshi Ishikawa, Sergei Boudko, Elena 
Pokidysheva 
 Shriners Hospital for Children, Portland, OR, USA 
THE ROLE OF PPIASES DURING PROCOLLAGEN BIOSYNTHESIS 
12:00 L-20 
Wanyun Xi, Chang Li, Hao Yu, Yih-Cherng Liou 
National University of Singapore, Singapore 
PIN1AT FUNCTIONS IN PLANT DEVELOPMENT 
 
12:20 - 14:00 Lunch break 
Session 3 
Chair: Maria Fiammetta Romano 
 
14:00 L-21 
Nwe Nwe Soe1, Mark Sowden1, Padmamalini Baskaran2, Yeonghwan 
Kim1, Patrizia Nigro3, Elaine M. Smolock1, Bradford C. Berk1 
1University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, 2University of 
Wyoming, Laramie, WY, USA,3Laboratorio di Biologia Vascolare e Medicine Rigenerative, 
Centro Cardiologico Monzino-IRCCS, Milano, Italy 
ACETYLATION OF CYCLOPHILIN A IS REQUIRED FOR ITS SECRETION 
AND SIGNALING IN VASCULAR CELLS 
14:45 L-22 
Peter Seizer, Saskia von Ungern-Sternberg, David Heinzmann, Christine 
S. Zuern, Andreas E. May 
Universitätsklinikum Tübingen, Tübingen, Germany 
CYCLOPHILIN A AND ITS EXTRACELLULAR RECEPTOR EMMPRIN 
(CD147) IN ISCHEMIC AND INFLAMMATORY CARDIOMYOPATHIES 
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15 
15:15 - 17:15 Microsymposium/Poster session I and coffee break 
Session 3 continued 
Chair: Steven D. Hanes 
 
17:15 L-23 
Jiyoung Oh, Zhong Jian Shen, James S. Malter 
 University of Texas Southwestern Medical Center, Dallas, TX, USA 




Tohoku University, Sendai, Japan 
SIGNIFICANCE OF PIN1- AND GAS7-KNOCK OUT MOUSE CREATION 
18:05 L-25 
Ana Y. Mercedes-Camacho, Guoyan G. Xu, Ashley B. Mullins, Matthew 
D. Mason, Felicia A. Etzkorn 
 Virginia Tech, Blacksburg, VA, USA 
 PIN1: INHIBITORS AND MECHANISM 
18:25 L-26 
Guy Lippens1, Isabelle Landrieu1, Caroline Smet1, Amina Kamah1, Julien 
Giustiniani2, Béatrice Chambraud2, Etienne Emile Baulieu2  
1Université de Lille, Villeneuve d'Ascq, France, 2Institut National de la Santé et de la Recherche 
Médicale, Le Kremlin-Bicêtre Cedex, France 
CONFORMATIONAL PROPERTIES OF THE PROLINES IN 
(PHOSPHORYLATED) TAU  
 
Saturday, September 21 
Session 4 
Chair: Franz. X. Schmid 
 
8:30 L-27 
Xiao Zhen Zhou, Kun Ping Lu 
Harvard Medical School, Boston, MA, USA 
THE PROLYL ISOMERASE PIN1 AS A SIGNALING REGULATOR AND A 
DRUG TARGET IN CANCER AND ALZHEIMER’S DISEASE 
9:15   L-28 
Steven D. Hanes 
SUNY Upstate Medical University, Syracuse, NY, USA 
THE ESS1 PROLYL ISOMERASE CONTROLS TRANSCRIPTION BY RNA 
POLYMERASE II 
9:45 L-29 
Leonard Kritharides, Maaike Kockx, Wendy Jessup  
 ANZAC Research Institute, University of Sydney, Sydney, Australia 
CYCLOSPORIN A IN ATHEROSCEROSIS, HYPERLIPIDEMIA, APOE 
SECRETION, AND REVERSE CHOLESTEROL TRANSPORT 
Cyclophilins and other Foldases 
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10:05 - 10:35 Coffee break 
Session 4 continued 
Chair: Guy Lippens 
 
10:35 L-30 
Urmi Doshi, Lauren McGowan, Safieh Tork Ladani, Donald Hamelberg 
 Georgia State University, Atlanta, GA, USA 
PROBING THE INTRICATE COUPLING BETWEEN ENZYME DYNAMICS 




 Brandeis University, Waltham, MA, USA 
THE CHOREOGRAPHY OF AN ENZYME'S DANCE - DYNAMICS DURING 
PROLYL ISOMERASES CATALYSIS 
11:35 L-32 
M. Dujardin1, R. Montserret2, V. Madan3, I. Huvent1, H. Launay1, A. 
Leroy1, F. Penin2, R. Bartenschlager3, G. Lippens1, X. Hanoulle1  
1Université Lille Nord de France, Lille, France; Université des Sciences et Technologies de Lille, 
Villeneuve d’Ascq, France, 2Université Lyon, Lyon, France, 3University of Heidelberg, 
Heidelberg, Germany 
THE CYCLOPHILIN A BINDING SITE ON THE INSTRINSICALLY 
DISORDERED DOMAIN 2 OF HCV NS5A CONTAINS A SHORT 
STRUCTURAL MOTIF THAT IS ESSENTIAL FOR VIRAL REPLICATION 
11:55 L-33 
Valentina Bonetto 
 Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy 
CYCLOPHILIN A IS A TRANSLATIONAL BIOMARKER AND A 
POTENTIAL THERAPEUTIC TARGET FOR AMYOTROPHIC LATERAL 
SCLEROSIS 
12:15 L-34 
Kyoungin Cho, Hemangi Patil, Jessica Wang, Haiqing Yi, Sunny Qiu, 
Paulo A. Ferreira 
 Duke University Medical Center, Durham, NC, USA 
 THE CYCLOPHILIN DOMAIN OF RANBP2 HARBORS DISCRIMINATING 
PHYSIOLOGICAL ACTIVITIES TOWARD DISTINCT BIOLOGICAL 
SUBSTRATES 
  
Cyclophilins and other Foldases 
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12:35 – 14:00 Lunch break 
Session 5 
Chair: Andreas E. May 
 
14:00 L-35 
Jun O. Liu 
 Johns Hopkins School of Medicine, Baltimore, Maryland, USA. 
FROM CYCLOPHILIN TO CALCINEURIN TO REGULATORS OF 
INTRACELLULAR CALCIUM SIGNALING PATHWAYS 
14:30 L-36 
Tatiana Iordanskaia1, Evan O. Nadler1, Dmitri Sviridov2, Miroslav 
Malesevic3, Michael Bukrinsky4 
1Children’s National Medical Center, Washington, DC, USA, 2Baker IDI Heart and Diabetes 
Institute, Melbourne, Australia, 3Martin-Luther-University Halle-Wittenberg, Halle (Saale), 
Germany, 4George Washington University School of Medicine and Health Sciences, 
Washington, DC, USA 
TREATING INFLAMMATORY DISEASES WITH EXTRACELLULAR 
CYCLOSPORINE 
 
15:00 - 16:50 Microsymposium/Poster session II and coffee break 
Session 5 continued 
Chair: Kun Ping Lu 
 
16:50 L-37 
Theodora Pappa1, Xianke Zeng1, Y’vonne Feeney1, Charles Clevenger2 
1Northwestern University, Chicago, IL, USA, 2Virginia Commonwealth University, Richmond, VA, 
USA 
NOVEL NON-IMMUNOSUPPRESSIVE CYCLOSPORINE ANALOGUES AS 
BREAST CANCER THERAPEUTICS 
17:20 L-38 
Thomas Ratajczak 
 Sir Charles Gairdner Hospital and The University of Western Australia, Nedlands WA, Australia 
STRUCTURE AND MULTIPLE FUNCTIONS OF CYCLOPHILIN 40, A 
TETRATRICOPEPTIDE REPEAT (TPR) CYCLOPHILIN 
17:40 L-39 
Eva Obermayr1,5, Dan Cacsire Castillo-Tong1, Dietmar Pils1, Paul 
Speiser1, Ioana Braicu2, Toon Van Gorp3,6, Sven Mahner4, Jalid Sehouli2, 
Ignace Vergote3, Robert Zeillinger1,51Medical University of Vienna, Vienna, Austria, 
2Charité - Universitätsmedizin Berlin, Berlin, Germany, 3Katholieke Universiteit Leuven, Leuven, 
Belgium, 4University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 5Ludwig 
Boltzmann Gesellschaft, Vienna, Austria, 6Present address: Maastricht UMC+, Maastricht, The 
Netherlands 
CYCLOPHILIN C IN CIRCULATING TUMOR CELLS 
  





Kimio Satoh, Yoshihiro Fukumoto, Koichiro Sugimura, Toru Shimizu, 
Kota Suzuki, Nobuhiro Kikuchi, Yusuke Takagi, Jun Takahashi, Hiroaki 
Shimokawa 
Tohoku University Graduate School of Medicine, Sendai, Japan 
CYCLOPHILIN A IS A NOVEL BIOMARKER FOR OXIDATIVE STRESS 
AND ATHEROSCLEROTIC DISEASES 
18:20 L-41 
Franz X. Schmid 
 Universität Bayreuth, Bayreuth, Germany 
 PROLYL ISOMERIZATION AS A RATE-DETERMING STEP IN PROTEIN 
FOLDING AND PROTEIN FUNCTION 
 
18:40 L-42 
Caroline Haupt, Michael Kovermann, Rica Patzschke, Mattias 
Altenstein, Jochen Balbach 
Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 
IN VITRO AND IN VIVO FUNCTION OF THE METALLOCHAPERONE SlyD 
 
  




Microsymposium I on Friday, September 20  
Chair: Jun O. Liu 
 
15:15 – 15:35 Short break 
15:35  P-38 
Manjusha M. Kulkarni1, Anna Karafova2, Wojciech Kamysz2, Sergio 
Schenkman3, Roger Pelle4, Bradford S. McGwire1 
1The Ohio State University Medical Center, Columbus, OH, USA, 2Medical University of Gdansk, 
Gdansk, Poland, 3Universidade Federal de Sao Paulo, Brazil, 4International Livestock Research 
Institute, Nairobi, Kenya 
SECRETED TRYPANOSOME CYCLOPHILIN INACTIVATES LYTIC 
INSECT DEFENSE PEPTIDES AND INDUCES PARASITE CALCINEURIN 
ACTIVATION AND INFECTIVITY 
15:43  P-41 
Piet Kramer, Andrea Hamann, Verena Warnsmann, Heinz D. Osiewacz  
J. W. Goethe University, Frankfurt, Germany 
ROLE OF CYCLOPHILIN D IN AGING AND LIFESPAN CONTROL OF 
PODOSPORA ANSERINA 
15:51  P-32 
Paul T. M. Lavin, Margaret M. Mc Gee  
Conway Institute, University College Dublin, Ireland 
CHARACTERISATION OF CYCLOPHILIN A LOCALISATION TO THE 
CENTROSOME AND MIDBODY IN TUMOUR CELLS  
15:59  P-58 
Iain McNae, Jacqueline Dornan, Jorge Dias Do Nascimento, Martin 
Wear, Malcolm Walkinshaw 
Centre for Translational and Chemical Biology, The University of Edinburgh, Scotland, UK 
CYCLOPHILIN IS A CHLORIDE ION SENSOR 
16:07  P-22 
Lionel Colliandre1, Abdelhakim Ahmed-Belkacem2, Muriel Gelin1, 
Yannick Bessin1, Jean-Michel Pawlotsly2, Jean-François Guichou1  
1Centre de Biochimie Structurale, CNRS, Montpellier, France, 2IMRB, Hôpital Henri Mondor, 
Créteil, France  
RATIONAL DESIGN OF SMALL-MOLECULES INHIBITORS OF HUMAN 
CYCLOPHILINS AND HCV REPLICATION BY STRUCTURE BASED 
DRUG DESIGN 
16:15  P-16 
Dhruv Shah1, Mohit Gupta1, Zandrea Ambrose2, Orlando Acevedo3, 
Patrick Flaherty1  
1Duquesne University, Pittsburgh, PA, USA, 2University of Pittsburgh School of Medicine, 
Pittsburgh, PA, USA, 3Auburn University, Auburn, AL, USA 
DESIGN, SYNTHESIS, AND TESTING OF TORSIONALLY RESTRICTED 
SMALL MOLECULE INHIBITORS OF CYCLOPHILIN A  
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16:23  P-14 
Maria Dimou, Aggeliki Skagia, Eleni Vezyri, Chrysoula Zografou, 
Anastasia Venieraki, Panagiotis Katinakis  
Agricultural University of Athens, Athens, Greece 
PEPTIDYL-PROLYL CIS/TRANS ISOMERASES ARE INVOLVED IN 
BACTERIAL MOTILITY AND BIOFILM FORMATION - STUDIES ON THE 
ROLE OF THE CYTOPLASMIC CYCLOPHILIN  
 
 
Microsymposium II on Saturday, September 21  
Chair: Felicia A. Etzkorn 
 
15:00 – 15:20 Short break 
15:20  P-21 
Steven J. Moss1, Jose A. Garcia-Rivera2, Pieter Leyssen3, Nigel Coates1, 
Udayan Chatterji2, Johan Neyts3, Philippe Gallay2, Barrie Wilkinson1, 
Mikael Brönnegård4, Jan Nilsson4, Matthew A. Gregory1 
1Isomerase Therapeutics Ltd., Cambridge, United Kingdom, 2The Scripps Research Institute, La 
Jolla, CA, USA, 3K.U.Leuven, Leuven, Belgium, 4Neurovive Pharmaceutical AB, Lund, Sweden 
BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, 
SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF 
CHRONIC HCV INFECTION 
15:28 P-62 
Sreekanth Rajan, Amaravadhi Harikishore, Ho Sup Yoon  
Nanyang Technological University, Singapore  
STRUCTURAL INSIGHTS INTO SUBSTRATE AND INHIBITOR BINDINGS 
BY PFFKBP35 AND PVFKBP35, PEPTIDYLPROLYL CIS-TRANS 
ISOMERASES FROM HUMAN MALARIAL PARASITES  
15:36 P-53 
Kunchithapadam Swaminathan  
National University of Singapore, Singapore  
STRUCTURAL INSIGHTS OF PLANT IMMUNOPHILINS  
15:44 P-39 
David Dilworth, Neda Savic, Christopher J. Nelson  
University of Victoria, Victoria, BC, Canada 
FUNCTIONS OF NUCLEAR FKBP PROTEINS 
15:52 P-57 
Esteban Vöhringer-Martinez 
Universidad de Concepción, Concepción, Chile 
MECHANISTIC INSIGHTS INTO THE PIN1 CATALYSIS OF CIS/TRANS 
PEPTIDE ISOMERIZATION 
16:00 P-27 
Nadja Bitomsky1, Dirk Sombroek1, Christian Moritz2, Kathrin 
Schultheiss1, Tilman Polonio-Vallon1, Elisa Conrad1, Carolina Glas1, 
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Fiamma Mantovani3, Giannino del Sal3, Francesca Peri2, Thomas G. 
Hofmann1 
1German Cancer Research Center DKFZ-ZMBH Alliance, Heidelberg, Germany, 2European 
Molecular Biology Laboratory (EMBL), Heidelberg, Germany, 3Laboratorio Nazionale CIB 
(LNCIB), Trieste, Italy 
CONSERVED MECHANISM OF ACTIVATION FOR DNA DAMAGE 
CHECKPOINT KINASE HIPK2 BY AUTOPHOSPHORYLATION AND PIN1 
BINDING 
16:08 P-13 
Alessandra Rustighi, Alessandro Zanini, Elena Campaner, Mattia 
Garutti, Giannino Del Sal 
National Laboratory CIB (LNCIB), Trieste, Italy 









Friday, September 20  Session I - posters with odd numbers 
Saturday, September 21  Session II - posters with even numbers 
 
P-01 Abdelhakim Ahmed-Belkacem, Lionel Colliandre, Nazim Ahnou, 
Yannick Bessin, Jean-François Guichou, Jean-Michel Pawlotsky 
INSERM/UPEC Hôpital Henri Mondor, Créteil, France 
NEW “DRUG-LIKE” CYCLOPHILIN INHIBITORS UNRELATED TO 
CYCLOSPORINE A POTENTLY INHIBIT HCV REPLICATION AND 
REVERT HCV-INDUCED MITOCHONDRIAL DYSFUNCTIONS 
 
P-02 Caroline Haupt, Matthias Altenstein, Jochen Balbach 
Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 
METALL-INDUCED PARAMAGNETIC RELAXATION ON PROTEINS 
 
P-03 Tobias Aumüller, Sandra Liebscher, Miroslav Malesevic, Günther 
Jahreis, Frank Bordusa, Cordelia Schiene-Fischer 
 Ulm University, Ulm, Germany 
DEVELOPMENT OF EFFICIENT AND VERSATILE ASSAYS TO 
QUANTIFY CYCLOPHILIN-INHIBITOR AFFINITY 
 
P-04 Lukas Hoppstock1, Martin Könneke2, Peter Bayer1 
1University of Duisburg-Essen, Essen, Germany, 2University of Bremen, Bremen, Germany 
STRUCTURE AND FUNCTION OF ARCHAEAL PARVULINS 
 
P-05 Wolfgang Rudolf Christian Beyer1, Gerd Hause2 Gunter Fischer1  
1Max-Planck Institute for Biophysical Chemistry Göttingen, BO Halle, Halle (Saale), Germany, 
2Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany  
PROBING AGGREGATION KINETICS OF Aβ PEPTIDE FRAGMENTS 
USING A MINIMAL BACKBONE SUBSTITUTION AND 
PHOTOISOMERIZATION  
 
P-06 Alessandra Bianchin1, Denis Shields1, Anthony J. Chubb1, Barrie 
Wilkinson2, Angus Bell3 
1University College Dublin, Ireland, 2Isomerase Therapeutics Ltd., UK, 3Moyne Institute, Trinity 
College Dublin, Ireland  
ANTIMALARIAL POTENTIAL OF NON-IMMUNOSUPPRESSIVE 
ANALOGUES OF RAPAMYCIN 
 
P-07 Annett Boden1, Weilin Lin1, Sonja Schallenberg2, Karsten Kretschmer2, 
Yixin Zhang1 
B CUBE, Technical University Dresden, Germany, 2CRTD/DFG-Center, Technical University 
Dresden, Germany  
LIGHT-SWITCHABLE CYCLOSPORIN A AS TOOL FOR 
IMMUNREGULATION 




P-08 Thomas Hediger1, Boris Féaux de Lacroix1, Fabian Kruska1, Nadira 
Dornhof1, Cordelia Schiene-Fischer2, and Manfred Braun1  
1University of Düsseldorf, Düsseldorf, Germany, 2Martin-Luther-University Halle-Wittenberg, 
Halle (Saale), Germany  
ARYL-INDANYL AND ARYL HETARYL KETONES AS NOVEL 
INHIBITORS OF PPIASES 
 
P-09 A. von Brunn1, J. Carbajo-Lozoya1, M. Malešević2, D. Muth3, Y. Ma-
Lauer1, B. von Brunn1, M. Su1, M. A. Müller3, G. Herrler4, C. 
Schwegmann-Weßels4, H.-J. Thiel5 , T. Baumert6, J. Haas7, C. Drosten3, 
G. Fischer2 
1Ludwig-Maximilians-University (LMU) Munich, Germany 2Martin-Luther-University Halle-
Wittenberg, Germany, 3University of Bonn, Germany, 4Tierärztliche Hochschule Hannover, 
Germany, 5Justus-Liebig Universität Gießen, Gießen, Germany, 6Université de Strasbourg, 
France, 7University of Edinburgh, UK 
FROM SARS-CORONAVIRUS (SARS-COV) ORFEOME TO CELLULAR 
TARGETS: INHIBITION OF CYCLOPHILINS BY CYCLOSPORINE A AND 
NON-IMMUNOSUPPRESSIVE DERIVATIVES RESULTS IN PAN-
CORONAVIRAL REPLICATION INHIBITION, INCLUDING THE NEW 
MERS-COV 
P-10 Y. Ma-Lauer1, J. Carbajo-Lozoya1, M. Malešević2, M. A. Müller3, G. 
Fischer2, C. Drosten3, A. von Brunn1 
1Max-von-Pettenkofer Institute, Ludwig-Maximilians-University Munich, Germany, 2Martin-
Luther-Universität Halle-Wittenberg, 3Institute of Virology, University of Bonn, Germany 
REPLICATION INHIBITION OF HUMAN CORONAVIRUSES SARS-COV, 
HCOV-NL63 AND HCOV-229E BY THE DRUG FK506 
 
P-11 P. Bustos1, A. Perrone1, M. Cámara2, A. Fuchs1,3, M. Postan1, S. 
Moreno4, J. Búa1,3 
1INP “Dr. M. Fatala Chaben” A.N.L.I.S.- Malbrán, Argentina, 2IDIM-CONICET, Argentina; 
3CAECIHS, UAI, Argentina, 4CTEGD, University of Georgia, USA 
A MITOCHONDRIAL CYCLOPHILIN FROM TRYPANOSOMA CRUZI AND 
ITS ROLE IN PROGAMMED CELL DEATH 
 
P-12 Steffi Stöhr1, Lisa Sandmann1, Stephanie Pfänder2, Michael P. Manns1, 
Eike Steinmann2, Thomas von Hahn1,3, Sandra Ciesek1 
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 
2Division of Experimental Virology, Medical School Hannover (MHH) and Helmholtz Centre for 
Infection Research (HZI), Hannover, Germany, 3Institute for Molecular Biology, Hannover 
Medical School, Hannover, Germany 
HOST MTORC1 SIGNALING IS REQUIRED FOR HEPATITIS C VIRUS 
(HCV) RNA REPLICATION 
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P-13 Alessandra Rustighi1,2, Alessandro Zanini1,2, Elena Campaner1,2, Mattia 
Garutti1,2, Giannino Del Sal1,2,3 
1National Laboratory CIB (LNCIB), Trieste, Italy, 2University of Trieste, Trieste, Italy 
ROLE OF THE PROLYL-ISOMERASE PIN1 IN BREAST CANCER 
AGGRESSIVENESS 
 
P-14 Maria Dimou, Aggeliki Skagia, Eleni Vezyri, Chrysoula Zografou, 
Anastasia Venieraki, Panagiotis Katinakis  
Agricultural University of Athens, Athens, Greece 
PEPTIDYL-PROLYL CIS/TRANS ISOMERASES ARE INVOLVED IN 
BACTERIAL MOTILITY AND BIOFILM FORMATION – STUDIES ON THE 
ROLE OF THE CYTOPLASMIC CYCLOPHILIN 
 
P-15 Franziska Todt, Zeynep Cakir, Frank Reichenbach, Frank Edlich 
Albert-Ludwigs-Universität Freiburg, Freiburg, Germany  
RETROTRANSLOCATION OF BAX AND BAK FROM THE 
MITOCHONDRIA INTO THE CYTOSOL 
 
P-16 Dhruv Shah1, Mohit Gupta1, Zandrea Ambrose2, Orlando Acevedo3, 
Patrick Flaherty1 
1Duquesne University, Pittsburgh, USA, 2University of Pittsburgh School of Medicine, Pittsburgh, 
USA 3Auburn University, Auburn, USA 
DESIGN, SYNTHESIS, AND TESTING OF TORSIONALLY RESTRICTED 
SMALL MOLECULE INHIBITORS OF CYCLOPHILIN A 
 
P-17 R. Gopalakrishnan1, S. Gaali2, X. Feng2, C. Kozany2, B. Hoogeland2, 
A. Bracher2, F. Hausch2 
1École Polytechnique Fédérale de Lausanne, Switzerland, 2Max-Planck-Institut for Psychiatry 
Munich, Germany 
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR THE 
FK506-BINDING PROTEINS 51 AND 52 
 
P-18 Y. Wang1, S. Gaali2, A. Kirschner2, A. Fabian2, R. Gopalakrishnan2, C. 
Kress2, B. Hoogeland2, U. Koch2, C. Kozany2, A. Bracher2, F. Hausch2 
1EMBL, 2Max-Planck-Institut for Psychiatry Munich, Germany 
INCREASING LIGAND EFFICIENCY BY CONFORMATIONAL CONTROL 
 
P-19 Himal K. Ganguly, Gautam Basu 
Department of Biophysics, Bose Institute, Kolkata, India 
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P-20 Julien Giustiniani1, Béatrice Chambraud1, Elodie Sardin1, Omar 
Dounane1, Kevin Guillemeau1, Hiroko Nakatani1, Dominik Paquet2,3, 
Amina Kamah4, Isabelle Landrieu4, Guy Lippens4, Etienne Emile 
Baulieu1, Marcel Tawk1 
1Institut National de la Santé et de la Recherche Médicale, Le Kremlin-Bicêtre Cedex, France, 
2,3Leopoldina Research Fellow, Tessier-Lavigne Laboratory, The Rockefeller University, New 
York, USA, 4Université de Lille1, Villeneuve d'Ascq, France 
PHYSIO-PATHOLOGICAL RELEVANCE OF FKBP52 AND TAU 
CONNECTION 
 
P-21 Steven J. Moss1, Jose A. Garcia-Rivera2, Pieter Leyssen3, Nigel Coates1, 
Udayan Chatterji2, Johan Neyts3, Philippe Gallay2, Barrie Wilkinson1, 
Mikael Brönnegård4, Jan Nilsson4, Matthew A. Gregory1 
1Isomerase Therapeutics Ltd., Cambridge, UK, 2The Scripps Research Institute, La Jolla, USA, 
3Rega Institute for Medical Research, K.U.Leuven, Belgium, 4Neurovive Pharmaceutical AB, 
Lund, Sweden 
BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, 
SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF 
CHRONIC HCV INFECTION 
 
P-22 Lionel Colliandre1, Abdelhakim Ahmed-Belkacem2, Muriel Gelin1, 
Yannick Bessin1, Jean.-Michel Pawlotsly2, Jean.-François Guichou1 
1Centre de Biochimie Structurale, Montpellier 1, France, 2IMRB, Hôpital Henri Mondor, Créteil, 
France 
RATIONAL DESIGN OF SMALL-MOLECULES INHIBITORS OF HUMAN 
CYCLOPHILINS AND HCV REPLICATION BY STRUCTURE BASED 
DRUG DESIGN 
 
P-23 D. Heinzmann1, P. Seizer1, S. von Ungern-Sternberg1, H. Sturhan1, T. 
Schönberger1, K. Klingel2, G. Fischer3, Z. Kaya4, A. E. May1 
1Medizinische Klinik III, Universitätsklinikum Tübingen, Germany, 2Institute of Molecular 
Pathology, Universitätsklinikum Tübingen, Germany, 3Max Planck Research Unit for 
Enzymology of Protein Folding, Halle (Saale), Germany, 4Department of Cardiology, 
Universitätsklinikum Heidelberg, Germany 
INHIBITION OF EXTRACELLULAR CYCLOPHILIN A DIMINISHES 
LEUKOCYTE INFILTRATION AND MYOCARDIAL REMODELLING IN A 
MOUSE MODEL OF AUTOIMMUNE MYOCARDITIS 
 
P-24 Morkos A. Henena,b, Cillian Byrnec, Amina Khamaa, Isabelle Landrieua,b, 
Guy Lippensa, Yves Jacquotc 
aCNRS, Lille1 University, France, bInstitute de Recherches interdisciplinaires, VILLENEUVE 
D'ASCQ, France, cPierre and Marie Curie University, Paris, France 
NMR AND DRUG DESIGN STUDIES OF INTERACTION BETWEEN 
FKBP52-PPIASE DOMAIN & POTENTIAL PEPTIDE AND 
PSEUDOPEPTIDE SUBSTRATES 
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P-25 Erik Hinze1, Wolfgang Rudolf Christian Beyer2, Angelika Schierhorn3, 
Cordelia Schiene-Fischer3 
1Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany 2Max-
Planck Institute for Biophysical Chemistry Göttingen, BO Halle, Germany, 3 Martin-Luther-
University Halle-Wittenberg, Halle (Saale), Germany 
INCORPORATING A REVERSIBLE CIS/TRANS PEPTIDE BOND 
PHOTOSWITCH INTO THE BACKBONE OF E.COLI PARVULIN 10 
 
P-26 Henrik Hoffmann1, Mario Träger 2, Cordelia Schiene-Fischer1 
1Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany, 2Max Planck Research Unit 
for Enzymology of Protein Folding, Halle (Saale), Germany 
CYP60 AND CYP57 - HUMAN MULTIDOMAIN CYCLOPHILINS 
COMPLEMENTED WITH DIFFERENT FUNCTIONAL DOMAINS 
 
P-27 Nadja Bitomsky1, Dirk Sombroek1, Christian Moritz2, Kathrin 
Schultheiss1, Tilman Polonio-Vallon1, Elisa Conrad1, Carolina Glas1, 
Fiamma Mantovani3, Giannino del Sal3, Francesca Peri2, Thomas G. 
Hofmann1 
1German Cancer Research Center (dkfz) DKFZ-ZMBH Alliance, Heidelberg, Germany, 
2European Molecular Biology Laboratory (EMBL), Heidelberg, Germany, 3Laboratorio Nazionale 
CIB (LNCIB), Trieste, Italy 
CONSERVED MECHANISM OF ACTIVATION FOR DNA DAMAGE 
CHECKPOINT KINASE HIPK2 BY AUTOPHOSPHORYLATION AND PIN1 
BINDING 
 
P-28 Yun Huang1,2, Günther Jahreis1, Christian Lücke1, Gunter Fischer1,3 
1Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany, 
2Present address: University of Pennsylvania, Philadelphia, USA, 3Present address: Max-Planck 
Institute for Biophysical Chemistry, Göttingen, BO Halle, Germany 
SELENOXO PEPTIDE BOND: NEW TOOL TO STUDY THE STRUCTURE 
AND FUNCTION OF PEPTIDE BACKBONE 
 
P-29 A. März, A. Kirschner, A. Fabian, C. Kozany, A. Bracher, F. Hausch 
Max-Planck-Institut for Psychiatry Munich, Germany 
LARGE FK506-BINDING PROTEINS CONTRIBUTE TO THE 
PHARMACOLOGY OF RAPAMYCIN 
 
 
P-30 M. Kockx1, E. Glaros2, T. W. Ng3, P. J. Meikle3, V. Deswaerte4, W. 
Jessup1, L. Kritharides1,5 
1ANZAC Research Institute, Sydney, 2Centre for Vascular Research, UNSW, Sydney, 
3Metabolomics, Baker IDI Heart and Diabetes Institute, Melbourne, 4Vascular Biology & 
Atherosclerosis, Baker IDI Heart and Diabetes Institute, Melbourne, 5University of Sydney, 
Sydney, Australia 
CYCLOSPORIN A CAUSES HYPERLIPIDEMIA IN THE LDLRKNOCKOUT 
MOUSE 
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P-31 Lorenz Korbinian Kollmannsberger, Nils Christian Gassen, Theo Rein 
Max-Planck Institute of Psychiatry, Munich, Germany 
DOES FKBP51 REGULATE GR TRANSCRIPTIONAL ACTIVITY BY 
RECRUITING KINASES AND PHOSPHATASES? 
 
P-32 Paul T. M. Lavin, Margaret M. Mc Gee 
Conway Institute, University College Dublin, Ireland 
CHARACTERISATION OF CYCLOPHILIN A LOCALISATION TO THE 
CENTROSOME AND MIDBODY IN TUMOUR CELLS 
 
P-33 Alfons Lawen1, Tony Velkov1,2 
Monash University, 1Department of Biochemistry and Molecular Biology, School of Biomedical 
Sciences and 2Monash Institute of Pharmaceutical Sciences, Melbourne, Australia 
FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF THE N-
METHYLTRANSFERASE MODULES IN CYCLOSPORIN SYNTHETASE 
 
P-34 Darren Leneghan, Angus Bell 
Moyne Institute of Preventive Medicine, Trinity College Dublin, Dublin 2, Ireland 
IMMUNOPHILIN-PROTEIN INTERACTIONS IN THE MALARIA PARASITE,  
PLASMODIUM FALCIPARUM 
 
P-35 Weilin Lin, Yixin Zhang 
B CUBE, Center for Molecular Bioengineering, Technical University Dresden, Germany 
A REINVESTIGATION OF CYCLOPHILIN - CYCLOSPORIN BINDING 
KINETICS 
 
P-36 Yoan Monneau1, Heddy Soufari1, Christopher Nelson2, Cameron 
Mackereth1 
1European Institute of Chemistry and Biology, Bordeaux, France, 2University of Victoria, Canada 
STRUCTURE OF YEAST FPR4 CATALYTIC DOMAIN AND HISTONE H3  
PROLINE ISOMERIZATION 
 
P-37 Miroslav Malešević  
Martin-Luther-University Halle Wittenberg, Halle (Saale), Germany  
SYNTHESIS OF A LIBRARY OF CYCLOSPORIN A (CSA) ANALOGUES 
VIA ALDEHYDE DIAMINE “CLICK” CHEMISTRY 
 
P-38 Manjusha M. Kulkarni1, Anna Karafova2, Wojciech Kamysz2, Sergio 
Schenkman3, Roger Pelle4, Bradford S. McGwire1 
1The Ohio State University Medical Center, Columbus, USA, 2Medical University of Gdansk, 
Gdansk, Poland, 3Universidade Federal de Sao Paulo, Brazil, 4International Livestock Research 
Institute, Nairobi, Kenya 
SECRETED TRYPANOSOME CYCLOPHILIN INACTIVATES LYTIC 
INSECT DEFENSE PEPTIDES AND INDUCES PARASITE CALCINEURIN 
ACTIVATION AND INFECTIVITY 
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P-39 David Dilworth, Neda Savic, Christopher J. Nelson 
University of Victoria, Victoria, BC, Canada 
FUNCTIONS OF NUCLEAR FKBP PROTEINS 
 
P-40 I. H. Norville1, D. W. Begley2, D. Fox III2, D. Jenner1, F. Seufert4, C. Juli4, 
N. J. Harmer5, R. Stacy3, P. J. Myler3, U. Holzgrabe4, D. Lorimer2,  M. 
Sarkar-Tyson1,6 
1Dstl, Porton Down, Salisbury, UK, 2Emerald Bio, Bainbridge Island, USA, 3Seattle Biomed, 
Seattle, USA, 4University Würzburg, Germany, 5University of Exeter, Devon, UK, 6University of 
Western Australia, Nedlands, Australia 
EVALUATION OF NOVEL INHIBITORS AGAINST BURKHOLDERIA 
PSEUDOMALLEI MIP PROTEIN 
 
P-41 Piet Kramer, Andrea Hamann, Verena Warnsmann, Heinz D. Osiewacz 
J. W. Goethe University, Frankfurt, Germany 
ROLE OF CYCLOPHILIN D IN AGING AND LIFESPAN CONTROL OF 
PODOSPORA ANSERINA 
 
P-42 Rica Patzschke1, Caroline Haupt, Michael Kovermann, Ulrich Weininger, 
Stefan Gröger1
 
 Jochen Balbach1 
Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 
STRUCTURAL INVESTIGATIONS ON ASSISTED PROTEIN FOLDING 
REACTIONS IN REAL-TIME 
 
P-43 Judith Toneatto1, Mario Galigniana2,3, Graciela Piwien-Pilipuk1 
1Laboratory of Nuclear Architecture and 2Laboratory of Nuclear Receptors, Instituto de Biologia y 
Medicina Experimental (IBYME) & 3University of Buenos Aires. Buenos Aires, Argentina 
PKA DEPENDENT MITOCHONDRIAL –NUCLEAR REDISTRIBUTION OF 
FKBP51 IS REQUIRED FOR THE CONTROL OF GENE EXPRESSION 
DURING THE PROCESS OF ADIPOGENESIS 
 
P-44 Simona Romano, Anna D’Angelillo, Marika Elsa Friano, Paolo D’Arrigo, 
Rita Bisogni, Maria Fiammetta Romano 
University of Naples - Federico II - Italy 
FKBP51 PROMOTES ACETYLATION OF YIN YANG 1 AND REDUCES 
TRAIL-R EXPRESSION IN MELANOMA 
 
P-45 G. Rühter1, M. Baumann1, K. Dinkel1, B. Klebl1, M. Malesevic3, P. 
Nussbaumer1, G. Fischer2 
1Lead Discovery Center GmbH, Dortmund, Germany 2Max-Planck Institute for Biophysical 
Chemistry Göttingen, BO Halle, Germany, 3Martin-Luther-University Halle-Wittenberg, Germany 
SPECIFIC TARGETING OF EXTRACELLULAR CYCLOPHILINS FOR 
TREATMENT OF INFLAMMATORY DISEASES 
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P-46 Miroslav Malesevic1, Danny Gutknecht2, Erik Prell3, Claudia Klein2, 
Romana A. Nowak4, Jan C. Simon2, Anja Saalbach2, Cordelia Schiene-
Fischer1 
1Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany, 2 Leipzig University, 
Leipzig, Germany, 3Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), 
Germany, 4University of Illinois, Illinois, USA 
ANTI-INFLAMMATORY EFFECTS OF EXTRACELLULAR 
CYCLOSPORINS ARE EXCLUSIVELY MEDIATED BY CD147 
 
P-47 Philipp A. M. Schmidpeter1, Gabriel Zoldák1, Tobias Aumüller2, Günther 
Jahreis2, Gunter Fischer2, Franz X. Schmid1 
1University of Bayreuth, Bayreuth, Germany, 2Max-Planck Research Unit for Enzymology of 
Protein Folding, Halle (Saale), Germany 
SEQUENCE SPECIFICITY OF PEPTIDYL-PROLYL ISOMERASES 
 
P-48 Michael Schumann1, Miroslav Malešević2, Sebastian Mathea1, Wolfgang 
Haehnel3†, Cordelia Schiene-Fischer2 
1Max-Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany, 2Martin-
Luther-University Halle-Wittenberg, Halle (Saale), Germany, 3Albert-Ludwigs-University, 
Freiburg, Germany 
REGULATION OF MCM3 CHROMATIN BINDING BY THE PROLYL 
ISOMERASE PIN1 
 
P-49 Alexandra Schutkowski1, Johannes Zerweck2, Mike Schutkowski3 
1Institute of Agricultural and Nutritional Sciences, Martin-Luther-University Halle-Wittenberg, 
Halle (Saale), Germany, 2JPT Peptide Technologies GmbH, Berlin, Germany, 3Institute of 
Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), 
Germany 
PEPTIDE MICROARRAYS FOR RELIABLE IDENTIFICATION OF 
PHOSPHORYLATION SITES IN HUMAN CYCLOPHILINS, FKBP´S AND 
PARVULINS 
 
P-50 F. Seufert1, C. Juli1, M. Hein1, I. H. Norville2, D. Jenner2; M. Sarkar-
Tyson2, M. Weiwad3, K. Schweimer4, P. Rösch4, R. Stacy6, P. Myler6, D. 
Begley5, D. Fox5, D. Lorimer5, C. A. Sotriffer1, U. Holzgrabe1 
1University of Würzburg, Würzburg, Germany, 2Defence Science and Technology Laboratory, 
Porton Down, Salisbury, UK, 3Research Center for Enzymology of Protein Folding, Max-Planck 
Institute Halle, Halle, Germany, 4University of Bayreuth, Bayreuth, Germany, 5Emerald 
BioStructures, Bainbridge Island, USA, 6Seattle Structural Genomics Center for Infectious 
Disease, Seattle, USA 
DEVELOPMENT OF MIP-INHIBITORS 
 
P-51 Ann Sluder, Robert Foglesong, Bernard Scorneaux, Richard Harris, 
Seong-Hee Park, Steve Wring, Michael Peel 
SCYNEXIS, Inc., Research Triangle Park, USA 
A NOVEL CYCLOPHILIN D INHIBITOR FOR PREVENTING MUSCLE 
LOSS CAUSED BY MITOCHONDRIAL STRESS 




P-52 Martin Helmuth1, Werner Schmidt1, Thomas Hediger2, Manfred Braun2, 
Gunter Fischer3, Frank Striggow1 
1German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany, 2University of 
Düsseldorf, Düsseldorf, 2Max-Planck Institute for Biophysical Chemistry Göttingen, BO Halle, 
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